Iovance Biotherapeutics, Inc. (IOVA)

NASDAQ: IOVA · Real-Time Price · USD

10.25

+0.23 (2.30%)

At close: Sep 18, 2026, 4:00 PM EDT

10.22

-0.03 (-0.29%)

After-hours: Sep 18, 2026, 7:57 PM EDT

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Amtagvi Revenue	273.32M	220.02M	103.57M
Proleukin Revenue	51.65M	43.48M	60.50M
Revenue (Total)	324.97M	263.50M	164.07M

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
United States Revenue	321.33M	259.01M	161.04M
Rest of World Revenue	3.64M	4.49M	3.03M
Revenue (Total)	324.97M	263.50M	164.07M